Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Kelly

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
American Journal of Clinical Pathology|September 20, 2021
Pathology Training for Cancer Diagnosis in AfricaDaniel J L Seymour, Katy M Graef, Yawale Iliyasu, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2024
Population pharmacokinetics of imetelstat, a first-in-class oligonucleotide telomerase inhibitorMario González-Sales, Ashley L Lennox, Fei Huang, et al.
Clinical and Translational Science|November 18, 2024
Imetelstat, a novel, first-in-class telomerase inhibitor: Mechanism of action, clinical, and translational scienceAshley L Lennox, Fei Huang, Melissa Kelly Behrs, et al.
American Journal of Clinical Pathology|May 7, 2025
ASCP explores the cancer biomarker testing navigator as a novel role to improve laboratory operations and workflows: A special report from the ASCP Biomarker Testing Navigator Project TeamLynnette Pineault, Karla Valencia, Jennifer Buhay, et al.
Clinical and Translational Science|February 20, 2025
Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational AnalysisAshley L Lennox, Libo Sun, Fei Huang, et al.
HRB Open Research|March 20, 2025
Data sources on COVID-19 infection and vaccination in pregnancy on the island of Ireland: strengths, weaknesses, and recommendations for future pandemic preparednessMelissa Kelly, Joanne Given, Julie Arnott, et al.
Genome Research|February 1, 2015
Actionable exomic incidental findings in 6503 participants: challenges of variant classificationLaura M Amendola, Michael O Dorschner, Peggy D Robertson, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
American Journal of Clinical Pathology|September 20, 2021
Pathology Training for Cancer Diagnosis in AfricaDaniel J L Seymour, Katy M Graef, Yawale Iliyasu, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2024
Population pharmacokinetics of imetelstat, a first-in-class oligonucleotide telomerase inhibitorMario González-Sales, Ashley L Lennox, Fei Huang, et al.
Clinical and Translational Science|November 18, 2024
Imetelstat, a novel, first-in-class telomerase inhibitor: Mechanism of action, clinical, and translational scienceAshley L Lennox, Fei Huang, Melissa Kelly Behrs, et al.
American Journal of Clinical Pathology|May 7, 2025
ASCP explores the cancer biomarker testing navigator as a novel role to improve laboratory operations and workflows: A special report from the ASCP Biomarker Testing Navigator Project TeamLynnette Pineault, Karla Valencia, Jennifer Buhay, et al.
Clinical and Translational Science|February 20, 2025
Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational AnalysisAshley L Lennox, Libo Sun, Fei Huang, et al.
HRB Open Research|March 20, 2025
Data sources on COVID-19 infection and vaccination in pregnancy on the island of Ireland: strengths, weaknesses, and recommendations for future pandemic preparednessMelissa Kelly, Joanne Given, Julie Arnott, et al.
Genome Research|February 1, 2015
Actionable exomic incidental findings in 6503 participants: challenges of variant classificationLaura M Amendola, Michael O Dorschner, Peggy D Robertson, et al.
Pageof 3